Comparative evaluation of NASBA HIV-1 RNA QT, AMPLICOR-HIV monitor, and QUANTIPLEX HIV RNA assay, three methods for quantification of human immunodeficiency virus type 1 RNA in plasma

Journal of Clinical Microbiology

Volumn 34, Issue 5, 1996, Pages 1058-1064

  Revets, H ^a,c   Marissens, D ^a   De Wit, S ^a   Lacor, P ^a   Clumeck, N ^b   Lauwers, S ^a   Zissis, G ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^b SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

^c VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; GENE AMPLIFICATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; VIREMIA; VIROGENESIS;

EID: 0029917922     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.34.5.1058-1064.1996     Document Type: Article

References (41)

1. Aboulker, J. P., and A. M. Swart. 1993. Preliminary analysis of the Concorde trial. Lancet 341:889-890.
2. Allain, J. P., D. A. Paul, Y. Laurian, and D. Senn. I986. Serological markers in early stages of human immunodeficiency virus infection in haemophiliacs. Lancet i:1233-1236.
3. Bagnarelli, P., S. Menzo, A. Valenza, S. Poalucci, S. Petroni, G. Scalise, R. Sampaolesi, A. Manzin, P. E. Varaldo, and M. Clementi. 1995. Quantitative molecular monitoring of human immunodeficiency virus type 1 activity during therapy with specific antiretroviral compounds J Clin Microbiol. 33: 16-23.
4. Boom, R., C. J. A. Sol, M. M. M. Salimans, C. L. Jansen, P. M. E. Wertheimvan Dillen, and J. van der Noordaa. 1990. A rapid and simple method for purification of nucleic acids. J. Clin. Microbiol. 28:495-503
5. Compton, J. 1991. Nucleic acid sequence-based amplification. Nature (London) 350:91-92.
6. Coombs, R. W., A. C. Collier, J. P. Allain, B. Nikora, M. Leuther, G. F. Gjerset, and L. Corey. 1989. Plasma viremia in human immunodeficiency virus infection. N Engl J. Med. 321:1626-1631.
7. Dewar, R. L., H. C. Highbarger, M. D. Sarmiento, J. A. Todd, M. B. Vasudevaehari, R. T. Davey, Jr., J. A. Kovacs, N. P. Salzman, H. C. Lane, and M. S. Urdea. 1994. Application of branched DNA signal amplification to monitor human immunodeficiency virus type 1 burden in human plasma. J. Infect. Dis. 170:1172-1179.
8. S. Goudsmit, J., F. De Wolf, D. A. Paul, L. G. Epstein, J. M. A. Lange, W. J. A. Krone, H. Speelman, E. C. Wolters, J. van der Noordaa, J. M. Oleske, H. J. van der Helm, and R. A. Couthino. 1986 Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection. Lancet ii:177-180.
9. Ho, D. D., T. Moudgil, and M. Alam. 1989. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. N. Engl. J. Med. 321:1621-1625.
10. Ho. D. D., A. U. Neumann, A. S. Perelson, W. Chen, J. M. Leonard, and M. Markowitz. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature (London) 373:123-126.
11. Holodniy, M., D. A. Katzenstein, D. M. Israelski, and T. C. Merigan. 1991. Reduction in plasma human immunodeficiency virus ribonucleic acid after didcoxynucieoside therapy as determined by the polymerase chain reaction. J Clin Invest. 88:1755-1759.
12. Holodniy, M., D. A. Katzenstein, S. Sengupta, A. M. Wang, C. Casipit, D. H. Schwartz, M. Konrad, E. Groves, and T. C. Merigan. 1991. Detection and quantification of human immunodeficiency virus RNA in patient serum by use of the polymerase chain reaction. J Infect Dis. 163:862-866.
13. Holodniy, M., D. A. Katzenstein, M. A. Winters, J. Montoya, R. Shafer, M. Kozal, M. Ragni, and T. C. Merigan. 1993. Gene amplification techniques to measure viral load and genotypic resistance in asymptomatic subjects treated with combination therapy. J Acquired Immune Defic Syndr. 6:366-369.
14. Horn, T., and M. Urdea. 1989. Forks and combs and DNA: the synthesis of branched oligodeoxyribonucleotides. Nucleic Acid Res 17:6959-6967.
15. Katzenstein, D. A., M. Holodniy, D. M. Israelski, S, Sengupta, L. A. Mole, J. L. Bubp, and T. C. Merigan. 1992. Plasma viremia on human immunodeficiency virus infection: relationship to stage of disease and antiviral treatment. J. Acquired Immune Defie. Syndr. 5:107-112.
16. Kievits, T., B. Van Gemen, D. Van Strijp, R. Schukkink, M. Dircks, H. Adriaanse, L. Malek, R. Sooknanan, and P. Lens. 1991. NASBA TM isothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis of HIV-1 infection. J. Virol Methods 35:273-286.
17. Kojima, E., T. Shirasaka, B. Anderson, S. Chokekijchai, S. Sei, R. Yarchoan, and H. Mitsuya. 1993. Monitoring the activity of antiviral therapy for HIV infection using a polymerase chain reaction method coupled with reverse transcription. AIDS 7(Suppl. 2):S101-S105
18. 17a. Koot, M., A. H. V. Vos, R. P. M. Keet, R. E. Y. De Goede, M. W. Derksen, F. G. Terpstra, R. A. Couthino, F. Miedema, and M. Tersmette. 1992. HIV-1 biological phenotype in long-term infected individuals evaluated with an MT-2 cocultivation assay. AIDS 6:49-54.
19. Kwok, S, S. Kinard, J. Spadoro, and J. J. Sninsky. 1992. Enhancement of PCR specificity by uracil-N-glycosylase. p. 67. In Abstracts of the 8th International Conference on AIDS, Amsterdam.
20. Lange, J. M. A., F. de Wolff, and J. Goudsmit. 1989. Markers for progression in HIV infection. AIDS 3:153-160
21. Lange, J. M. A., D. A. Paul, H. G. Huisman, F. de Wolf, H. van den Berg, R. A. Couthino, S. A. Danner, J. van der Noordaa, and J. Goudsmit. 1986 Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS Br. Med. J. 293:1459-1462
22. Lelie, P. N., H. W. Reesink, E. Bakker, J. G. Huisman, and J. Ten Veen. 1988. Clinical importance of HIV antigen and anti-HIV core markers in persons infected with HIV N. Engl. J. Med. 318:1204-1205.
23. Lin, H. J., L. E. Myers, B. Yen-Lieberman, F. B. Hollinger, D. Henrard, C. J. Hooper, R. Kokka, S. Kwok, S. Rasheed, M. Vahey, M. A. Winters, L. J. McQuay, P. L. Nara, P. Reichelderfer, R. W. Coombs, and J. B. Jackson. 1994. Multicenter evaluation of quantification methods for plasma human immunodeficiency virus type 1 RNA. J. Infect. Dis. 170:553-562.
24. Longo, M. C., M.S. Berninger, and J. L. Hartley. 1990. Use of uracil DNA glycosylase to control carry-over contamination in polymerase chain reactions. Gene 93:125-128
25. Loveday, C., S. Kaye, M. Tenant-Flowers, M. Simple, U. Ayliffe, I. V. D. Weller, and R. S. Tedder. 1995. HIV-1 RNA serum-load and resistent viral genotypes during eaily zidovudine therapy. Lancet 345:820-824.
26. Lu, W., and J. M. Andrieu. 1992. Early identification of human immunodeficiency virus-infected asymptomatic subjects susceptible to zidovudine by quantitative viral coculture and reverse transcription-linked polymerase chain reaction. J. Infect. Dis. 167:1014-1020
27. Mulder, J., N. McKinney, C. Christopherson, J. Sninsky, L. Greenfleld, and S. Kwok. 1994 Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma application to acute retroviral infection. J Chin. Microbiol. 32:292-300
28. Myers, T. W., and D. H. Gelfand. 1991. Reverse transcription and DNA amplification by a Theimus thermophilus DNA polymerase. Biochemistry 30: 7661-7666.
29. Nishanian, P., K. R. Huskins, S. Stehn, K. Detels, and J. L. Fahey. 1990 A simple method for improved assay that demonstrates that HIV p24 antigen is present as immune complexes in most sera from HIV-infected individuals. J. Infect. Dis. 162:21-28.
30. Pachl, C., J. A. Todd, D. G. Kern, P. J. Sheridan, S. J. Fong, M. Stempien. B. Hoo, D. Besemer, T. Yeghiazarian, B. Irvine, J. Kolberg, R, Kokka, P. Neuwald, and M. S. Urdea. 1995. Rapid and precise quantification of HIV-1 RNA in plasma using a branched DNA signal amplification assay J. Acquired Immune Defic Syndr. 8:446-454.
31. Pan, L.-Z., A. Werner, and J. A. Levy. 1993. Detection of plasma viremia in human immunodeficiency virus-infected individuals at all clinical stages. J. Clin. Microbiol. 31:283-288.
32. Paul, D. A., A. L. Falk, H. A. Kessler, R. M. Chase, B. Blaauw, and D. S. Chudwin. 1987. Correlation of serum HIV antigen and antibody with clinical status in HIV infected patients. J. Med. Virol. 22:351-363
33. Phillips, A. N., C. A. Lee, J. Elford, G. Janossy, A. Timms, M. Bofill, and P. B. A. Kernoff. 1991 Serial CD4 lymphocyte counts and development of AIDS. Lancet 337:389-392.
34. Piatak, M., Jr., M. S. Saag, L. C. Yang, S. J. Clark, J. C. Kappes, K.-C. Luk, B. H. Hahn, J. M. Shaw, and J. D. Lifson. 1993. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 259:1749-1754.
35. Reddy, M. M., E. E. Winger, D. Hargrove, T. McHugh, G. F. McKinley, and M. H. Grieco. 1992. An improved method for monitoring efficacy of antiretroviral therapy in HIV-1-infected individuals a highly sensitive HIV-1 p24 antigen assay. J. Clin. Lab. Anal. 6:125-129.
36. Semple, M., C. Loveday, I. Weller, and R. Tedder. 1991 Direct measurement of viraemia in patients infected with HIV-1 and its relationship to disease progression and zidovudine therapy. J. Med. Virol. 35:38-45.
37. Tsoukas, C. M., and N. F. Bernard. 1994. Markers predicting progression to human immunodeficiency virus-related disease. Clin. Microbiol. Rev. 7: 14-28.
38. Urdea, M. 1993 Synthesis and characterization of branched DNA (bDNA) for the direct and quantitative detection of CMV, HBV, HCV, and HIV. Clin. Chem. 39:725-726.
39. Van Gemen, B., T. Kievits, R. Schukkink, D. Van Strijp, L. T. Malek, R. Sooknanan, H. G. Huisman, and P. Lens. 1993. Quantification of HIV-1 RNA in plasma using NASBA TM during a HIV-1 primary infection. J. Virol. Methods 43:177-188
40. Wei, X., S. K. Ghosh, M. E. Taylor, V. A. Johnson, E. A. Emini, P. Deutsch, J. D. Lifson, S. Bonhoeffer, M. A. Nowak, B. H. Hahn, M. S. Saag, and G. M. Shaw. 1995. Viral dynamics in human immunodeficiency virus type 1 infection Nature (London) 373:117-122.
41. Winters, M. A., L. B. Tan, D. A. Katzenstein, and T. C. Merigan. 1993. Biological variation and quality control of plasma human immunodeficiency virus type 1 RNA quantitation by reverse transcriptase polymerase chain reaction. J. Clin. Microbiol 31:2960-2966.